IRIS
SCUTERI, DAMIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 883
AS - Asia 770
EU - Europa 413
SA - Sud America 223
OC - Oceania 12
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 2.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 846
SG - Singapore 367
IT - Italia 205
BR - Brasile 183
CN - Cina 171
IN - India 102
VN - Vietnam 68
GB - Regno Unito 49
DE - Germania 39
CA - Canada 24
FI - Finlandia 22
SE - Svezia 21
EC - Ecuador 14
HK - Hong Kong 12
AR - Argentina 10
IQ - Iraq 10
NL - Olanda 10
RU - Federazione Russa 10
EE - Estonia 9
MX - Messico 9
PL - Polonia 9
BD - Bangladesh 8
AT - Austria 7
TR - Turchia 7
ZA - Sudafrica 7
AU - Australia 6
FR - Francia 6
NZ - Nuova Zelanda 6
PE - Perù 6
ES - Italia 5
IE - Irlanda 5
TW - Taiwan 5
UA - Ucraina 5
CL - Cile 4
EU - Europa 4
JP - Giappone 4
RO - Romania 4
CO - Colombia 3
PK - Pakistan 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
HR - Croazia 2
ID - Indonesia 2
MA - Marocco 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
LT - Lituania 1
MD - Moldavia 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.319
Salva come PNG Salva come JPEG
Città #
Dallas 170
Singapore 156
Santa Clara 92
Bengaluru 88
Hefei 88
Ashburn 49
Chandler 48
Lawrence 38
Princeton 38
Milan 35
Chicago 33
Ho Chi Minh City 33
London 32
Beijing 23
Wilmington 22
Catanzaro 19
São Paulo 19
Los Angeles 18
Munich 18
Hanoi 15
Helsinki 15
Hong Kong 12
Redwood City 12
Des Moines 11
New York 11
Warsaw 9
Ann Arbor 8
Birmingham 8
Ottawa 7
Palermo 7
Rome 7
Turku 7
Vallefiorita 7
Brooklyn 6
Florence 6
Lima 6
Shenzhen 6
Amsterdam 5
Boardman 5
Boston 5
Chennai 5
Montreal 5
Phoenix 5
Quito 5
Rio de Janeiro 5
San Francisco 5
St Petersburg 5
Washington 5
Assago 4
Atlanta 4
Auckland 4
Charlotte 4
Guangzhou 4
Johannesburg 4
Manchester 4
Naples 4
Palizzi Marina 4
San Ferdinando 4
Shanghai 4
Stockholm 4
Taipei 4
The Dalles 4
Tokyo 4
Ankara 3
Aversa 3
Baghdad 3
Bologna 3
Brasília 3
Council Bluffs 3
Curitiba 3
Dublin 3
García 3
Hackney 3
Horia 3
Itaquaquecetuba 3
Mumbai 3
Rende 3
Rizziconi 3
Salvador 3
San Nicola Manfredi 3
Springfield 3
Thái Nguyên 3
Toronto 3
Viamão 3
Wuhan 3
Asunción 2
Bangkok 2
Bogotá 2
Buccinasco 2
Buenos Aires 2
Campinas 2
Can Tho 2
Carolei 2
Catania 2
Columbus 2
Cuenca 2
Detroit 2
Dhaka 2
Erbil 2
Feira de Santana 2
Totale 1.390
Salva come PNG Salva come JPEG
Nome #
Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs 73
Benefits and risks associated with cannabis and cannabis derivatives use 69
Pharmacoutilization data-driven artificial intelligence–assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia 61
Pain assessment and treatment in dementia at the time of coronavirus disease covid-19 54
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats. 53
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence 51
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs. 49
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial 48
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies. 46
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 45
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach. 44
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis 43
Impact of nutraceuticals on glaucoma: A systematic review 42
Focus on zavegepant: the first intranasal third-generation gepant 40
Evidence on the neuroprotective properties of brimonidine in glaucoma 39
Benefits and risks associated with cannabis and cannabis derivatives use 39
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues 38
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent 38
Aging brain: In search for better neurotherapeutics 37
New trends in pain research: from basic research to clinical translation 36
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 35
Pattern of triptans use: A retrospective prescription study in Calabria, Italy 33
Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats 33
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms 32
Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study 31
Efficacy and safety of mAbs anti-CGRP/CGRP R (eptinezumab and erenumab) or atogepant in combination with onabotulinumtoxinA in refractory chronic migraine: a clinical trial protocol 30
Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice 30
Essential oils for the control of the neuropsychiatric symptoms of dementia. A pharmacotechnological appraisal 29
The need for better access to pain treatment: learning from drug consumption trends in the USA. 29
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia 29
Development and translation of nanobeo, a nanotechnology-based delivery system of bergamot essential oil deprived of furocumarins, in the control of agitation in severe dementia 29
Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia 28
Eptinezumab for the treatment of migraine 28
Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia 28
Proposal of combination therapies to treat refractory chronic migraine 28
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 27
Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis 27
Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice 26
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence 26
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 26
Basic, Translational, and Clinical Research on Dementia 25
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 25
Pharmacokinetic interactions between herbal medicines and drugs: Their mechanisms and clinical relevance 25
New trends in pharmacological control of neuropsychiatric symptoms of dementia 25
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review 25
Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8 24
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 24
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine 24
Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation” 24
Dementia and COVID-19: A Case Report and Literature Review on Pain Management 23
Efficacy of essential oils in pain: A systematic review and meta-analysis of preclinical evidence 23
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 22
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 22
Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy 22
Aging Brain: In Search of Better Neurotherapeutics 22
Effect of gabapentin in a neuropathic pain model in mice overexpressing human wild-type or human mutated torsin a 22
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy 22
Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia 22
Aromatherapy in Stroke Patients: Is it Time to Begin? 21
Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions 21
Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation 21
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy. 20
Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing 20
Real world considerations for newly approved CGRP receptor antagonists in migraine care 19
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol 19
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation 19
Exploitation of thermal sensitivity and hyperalgesia in a mouse model of dystonia 19
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 18
Targeting Neuroplasticity for the Management of Pain and Agitation in Alzheimer’s Disease via Bergamot Nanotherapy 18
Dementia therapeutics and cognitive rehabilitation 17
Scopolamine-Induced Memory Impairment in Mice: Effects of PEA-OXA on Memory Retrieval and Hippocampal LTP 17
Opioids Resistance in Chronic Pain Management 17
Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol 17
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 17
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-Like Behaviour in Female Rats 17
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 16
Essential oils-induced analgesia and related translation for the management of agitation in dementia 16
Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia 16
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65 16
Homo-AMPA in the periaqueductal grey modulates pain and rostral ventromedial medulla activity in diabetic neuropathic mice 16
ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development 15
Unbiased research is needed for rational translation of essential oils in clinic 15
Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis 14
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia 12
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab 12
Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review 11
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 11
Epigenetic and nanotechnology alliance to fight stroke-induced brain damage 9
Totale 2.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 5 8 7 0 5 7 0 0 1
2021/2022122 4 1 2 13 5 22 9 21 6 15 23 1
2022/2023229 78 9 7 9 17 30 6 21 23 8 17 4
2023/2024194 44 18 14 10 14 45 7 6 4 5 24 3
2024/2025908 125 58 35 21 87 104 20 18 157 44 82 157
2025/2026868 86 314 198 270 0 0 0 0 0 0 0 0
Totale 2.446